Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (7)
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients
2000 • 553 citations
Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection
1998 • 206 citations
Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical use
1996 • 132 citations
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids
2000 • 81 citations
Efficacy and Safety of Desensitization With Sulfamethoxazole and Trimethoprim in 48 Previously Hypersensitive Patients Infected With Human Immunodeficiency Virus
1997 • 54 citations
Nevirapine-induced cutaneous hypersensitivity reactions and successful tolerance induction☆☆☆★
1999 • 27 citations
Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus
1997 • 13 citations